Guangzhou Xiangxue Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the board of directors guarantee that the content of this announcement is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
The Company held the 36th meeting of the 9th board of directors on June 5, 2026, and approved the proposal on the election of an independent director. The relevant matters are announced as follows:
1. Resignation of Directors
On June 5, 2026, the board of directors received a resignation report from Mr. Xu Li, who resigned from his position as a director for personal reasons, effective from the date the resignation report was delivered to the board. After his resignation, Mr. Xu will no longer hold any position in the Company. His resignation will not result in the board of directors falling below the legal minimum number of members and will not affect the normal operation of the board. The Company will complete the election of a new director as soon as possible in accordance with legal procedures. As of the date of this announcement, Mr. Xu holds 201,701 shares of the Company, accounting for 0.03% of the total share capital, and there are no unfulfilled commitments. After his resignation, he will continue to strictly comply with relevant laws and regulations regarding share changes. The board expresses sincere gratitude for Mr. Xu's contributions during his tenure.